NEXTBIO CAPITAL MANAGEMENT LP
Q1 2026 Form 13-F

MENLO PARK, DELAWARE
CIK 0002038158 · Institutional investment manager
$215.4M Reported Value Total
Reported value
$215.4M
Quarter over quarter
+14.9%
Holdings
24
Top-10 concentration
71.1%

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Ky Phan
CHIEF FINANCIAL OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2026 13F record

Q1 2026 13F filing summary

Q1 2026 Form 13F portfolio summary
Period of report March 31, 2026
Filed May 14, 2026
Form 13F-HR
Reported value $215.4M
Positions 24
Change in reported value +26.3%
New positions 1
Exited positions 0
Position turnover 4.2%
Top-10 concentration 71.1%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
25 $234.4M
Q2 2026 13F
Filed Aug 14, 2026
22 $217.4M
Q1 2026 13F
Filed May 14, 2026
24 $215.4M
Q4 2025 13F
Filed Feb 13, 2026
23 $170.5M

Top 20 holdings · Q1 2026

Largest Q1 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 TERN TERNS PHARMACEUTICALS INC $31.9M 14.8%
2 PTGX PROTAGONIST THERAPEUTICS INC $24.2M 11.24%
3 STTK SHATTUCK LABS INC $20.3M 9.4%
4 VOR VOR BIOPHARMA INC $17.8M 8.28%
5 CMPS COMPASS PATHWAYS PLC $11.2M 5.19%
6 RYTM RHYTHM PHARMACEUTICALS INC $11.0M 5.09%
7 XENE XENON PHARMACEUTICALS INC $10.7M 4.95%
8 PVLA PALVELLA THERAPEUTICS INC NE $10.3M 4.79%
9 ZBIO ZENAS BIOPHARMA INC $8.3M 3.87%
10 IVA INVENTIVA SA $7.4M 3.44%
11 VSTM VERASTEM INC $6.9M 3.22%
12 CBIO CRESCENT BIOPHARMA INC. $6.8M 3.18%
13 ORIC ORIC PHARMACEUTICALS INC $6.6M 3.08%
14 GPCR STRUCTURE THERAPEUTICS INC $6.4M 2.98%
15 PCVX VAXCYTE INC $5.5M 2.57%
16 COGT COGENT BIOSCIENCES INC $5.0M 2.34%
17 CMPX COMPASS THERAPEUTICS INC $4.5M 2.08%
18 EVMN EVOMMUNE INC $4.2M 1.96%
19 OCS OCULIS HOLDING AG $4.0M 1.85%
20 ZLAB ZAI LAB LTD $3.4M 1.6%

Values as reported on the Q1 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings